Blood Weekly

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Blood Weekly


We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Cardiology

Pioglitazone reduces neointima volume after coronary stent implantation

According to a study from Germany, "Restenosis requiring reintervention limits the long-term success after coronary stent implantation. Thiazolidinediones, like pioglitazone or rosiglitazone, are oral antidiabetic drugs with additional antirestenotic properties."

N. Marx and colleagues at the University of Ulm wrote, "We conducted a randomized, placebo-controlled, double-blind trial. We examined the effect of 6-month pioglitazone therapy on neointima volume after coronary stenting in nondiabetic coronary artery disease patients. Fifty nondiabetic patients after coronary stent...

• View Other Issues of Blood Weekly
  
• View Other NewsRx Publications